“…Specifically, the high-dose local administration may induce serious side effects (e.g., vasculitis, hyperpigmentation, etythema, purpura, burning sensation), and the invasive injection is accompanied with intense pain 15 , 16 . Compared to intralesional injection, microneedles (MNs) have attracted significant interests as a new promising transdermal drug delivery platform, due to nonselective loading capacity, minimal invasiveness, simple operation and good biocompatibility 17 , 18 . Specifically, endogenous stimuli-responsive MNs in response to pathological microenvironment serves as simple and convenient local administration, providing an opportunity for sustainable drug release to enhance the efficacy of drug delivery and minimize the potential side effects 19 , 20 .…”